These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3279 related articles for article (PubMed ID: 7427881)

  • 21. The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin.
    Albert DM; Chang MA; Lamping K; Weiter J; Sober A
    Ophthalmology; 1985 Dec; 92(12):1728-34. PubMed ID: 4088626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo melanoma and melanoma arising from pre-existing nevus: in vivo morphologic differences as evaluated by confocal microscopy.
    Longo C; Rito C; Beretti F; Cesinaro AM; Piñeiro-Maceira J; Seidenari S; Pellacani G
    J Am Acad Dermatol; 2011 Sep; 65(3):604-614. PubMed ID: 21715047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between melanocytic nevi and malignant melanoma.
    Friedman RJ; Rigel DS; Heilman ER
    Dermatol Clin; 1988 Apr; 6(2):249-56. PubMed ID: 3378371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of cutaneous melanoma in melanocytic nevi.
    Fernandes NC
    An Bras Dermatol; 2013; 88(2):314-5. PubMed ID: 23739702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study.
    Carli P; Massi D; Santucci M; Biggeri A; Giannotti B
    J Am Acad Dermatol; 1999 Apr; 40(4):549-57. PubMed ID: 10188672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysplastic Nevi: Morphology and Molecular and the Controversies In-between.
    Wiedemeyer K; Hartschuh W; Brenn T
    Surg Pathol Clin; 2021 Jun; 14(2):341-357. PubMed ID: 34023110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Number of melanocytic nevi as a major risk factor for malignant melanoma.
    Holly EA; Kelly JW; Shpall SN; Chiu SH
    J Am Acad Dermatol; 1987 Sep; 17(3):459-68. PubMed ID: 3655025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
    Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
    J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
    Ackerman AB; Mihara I
    Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
    [No Abstract]   [Full Text] [Related]  

  • 33. Histogenesis of cutaneous malignant melanoma: The vast majority do not develop from melanocytic nevus but arise de novo as melanoma in situ.
    Saida T
    J Dermatol; 2019 Feb; 46(2):80-94. PubMed ID: 30632197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
    Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age distribution and histologic patterns of dysplastic nevi.
    Sagebiel RW; Banda PW; Schneider JS; Crutcher WA
    J Am Acad Dermatol; 1985 Dec; 13(6):975-82. PubMed ID: 4078104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
    Hussein MR
    J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual dysplastic and other nevi in superficial spreading melanoma. Clinical correlations and association with sun damage.
    Black WC
    Cancer; 1988 Jul; 62(1):163-73. PubMed ID: 3383113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fluorescence of melanocytic lesions.
    Temple-Camp CR; Hainsworth M
    Am J Dermatopathol; 1986 Aug; 8(4):290-4. PubMed ID: 3766918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cutaneous evolution of nevi in a patient with familial, atypical, multiple-mole melanoma syndrome.
    Lynch HT; Fusaro RM; Treger CL; Pester J; Lynch JF
    Pediatr Dermatol; 1985 Jul; 2(4):289-93. PubMed ID: 4011507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 164.